2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow PET Scan: new trials by email Literature Review of PET Scan trials Research Report on PET Scan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma Computed Tomography, Dacarbazine, Doxorubicin Hydrochloride - Classical Hodgkin Lymphoma, Lymphocyte-Depleted Classical Hodgkin Lymphoma | Phase 2 | Unknown | Northwestern University | 30 | 2017-11-09 | 2023-06-02 |
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment Cyclophosphamide, Doxorubicin, Vincristine - Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma | Phase 2 | Unknown | British Columbia Cancer Agency | 150 | 2006-08-01 | 2021-07-22 |
Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1)
British Columbia Cancer Agency (1) · Northwestern University (1)
Canada (1) · United States (1)
Jane Winter, M.D. (1) · Laurie H Sehn, MD (1)
PMID 32992341, PMID 36083129, PMID 40135712
P30CA060553 (1)